NO20025209D0 - Cyclipostins, their preparation and use - Google Patents

Cyclipostins, their preparation and use

Info

Publication number
NO20025209D0
NO20025209D0 NO20025209A NO20025209A NO20025209D0 NO 20025209 D0 NO20025209 D0 NO 20025209D0 NO 20025209 A NO20025209 A NO 20025209A NO 20025209 A NO20025209 A NO 20025209A NO 20025209 D0 NO20025209 D0 NO 20025209D0
Authority
NO
Norway
Prior art keywords
physiologically compatible
cyclipostins
compounds
relates
chemical equivalents
Prior art date
Application number
NO20025209A
Other languages
Norwegian (no)
Other versions
NO20025209L (en
NO330438B1 (en
Inventor
Lsszlo Vurtesy
Klaus Ehrlich
Michael Kurz
Joachim Wink
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20025209L publication Critical patent/NO20025209L/en
Publication of NO20025209D0 publication Critical patent/NO20025209D0/en
Publication of NO330438B1 publication Critical patent/NO330438B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • C07F9/65744—Esters of oxyacids of phosphorus condensed with carbocyclic or heterocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P9/00—Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention relates to compounds of the general formula (I), wherein R<1>, R<2>, E, X1, X2 and X3 have the definitions in this application, obtained by the cultivation of the Streptomyces species HAG 004107 (DSM 13381) and to the physiologically compatible salts and chemical equivalents of said compounds. The invention also relates to a method for producing the cyclipostins and their physiologically compatible salts and chemical equivalents as medicaments, in particular as inhibitors of lipases, and to pharmaceutical preparations containing cyclipostin or a physiologically compatible salt or equivalent thereof.
NO20025209A 2000-05-04 2002-10-30 Cyclipostins, their preparation and use as well as pharmaceutical preparation and microorganism NO330438B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10021731A DE10021731B4 (en) 2000-05-04 2000-05-04 Cyclipostins, process for their preparation and pharmaceutical preparation thereof
PCT/EP2001/004652 WO2001083497A1 (en) 2000-05-04 2001-04-25 Cyclipostins, a method for their production and the use of the same

Publications (3)

Publication Number Publication Date
NO20025209L NO20025209L (en) 2002-10-30
NO20025209D0 true NO20025209D0 (en) 2002-10-30
NO330438B1 NO330438B1 (en) 2011-04-11

Family

ID=7640768

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025209A NO330438B1 (en) 2000-05-04 2002-10-30 Cyclipostins, their preparation and use as well as pharmaceutical preparation and microorganism

Country Status (28)

Country Link
EP (1) EP1280812B1 (en)
JP (1) JP5038572B2 (en)
KR (1) KR100779867B1 (en)
CN (1) CN1216890C (en)
AR (1) AR028398A1 (en)
AT (1) ATE288442T1 (en)
AU (2) AU2001262229B2 (en)
BR (1) BR0110459A (en)
CA (1) CA2407808C (en)
CZ (1) CZ20023547A3 (en)
DE (2) DE10021731B4 (en)
DK (1) DK1280812T3 (en)
EE (1) EE05090B1 (en)
ES (1) ES2236234T3 (en)
HK (1) HK1055745A1 (en)
HR (1) HRP20020864A2 (en)
HU (1) HUP0300306A3 (en)
IL (2) IL152612A0 (en)
MX (1) MXPA02010297A (en)
NO (1) NO330438B1 (en)
NZ (1) NZ522352A (en)
PL (1) PL358328A1 (en)
PT (1) PT1280812E (en)
RU (1) RU2266911C2 (en)
SK (1) SK15602002A3 (en)
WO (1) WO2001083497A1 (en)
YU (1) YU81502A (en)
ZA (1) ZA200208928B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8110665B2 (en) 2003-11-13 2012-02-07 Hanmi Holdings Co., Ltd. Pharmaceutical composition comprising an immunoglobulin FC region as a carrier
EP1682582B1 (en) 2003-11-13 2011-08-31 Hanmi Holdings Co., Ltd Method for the mass production of immunoglobulin constant region
KR100754667B1 (en) 2005-04-08 2007-09-03 한미약품 주식회사 Immunoglobulin Fc fragment modified by non-peptide polymer and pharmaceutical composition comprising the same
EP1894601A1 (en) 2006-08-29 2008-03-05 sanofi-aventis Treating mycobacterial infections with cyclipostins
KR200453850Y1 (en) * 2008-04-23 2011-05-30 주식회사 에이티티알앤디 Water meter
KR102073748B1 (en) 2013-01-31 2020-02-05 한미약품 주식회사 Recombinant yeast transformant and process for preparing immunoglobulin Fc fragment employing the same
AR096891A1 (en) 2013-07-12 2016-02-03 Hanmi Pharm Ind Co Ltd CONJUGATE OF BIOMOLOGICALLY ACTIVE POLYPEPTIDE MONOMER AND CONJUGATE OF FRAGMENTO FC OF IMMUNOGLOBULINA, THAT SHOWS CLEARING THROUGH REDUCED RECEPTOR, AND THE METHOD FOR PREPARING THE SAME

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04145089A (en) * 1990-10-05 1992-05-19 Nippon Kayaku Co Ltd Antibiotic nk901093, production thereof and insecticide and acaricide comprising the same antibiotic as active ingredient
JPH0656859A (en) * 1991-07-25 1994-03-01 Nippon Kayaku Co Ltd Antibiotic nk901093a, its production and pesticidal and miticidal agent containing the same compound as active component

Also Published As

Publication number Publication date
ES2236234T3 (en) 2005-07-16
EP1280812A1 (en) 2003-02-05
KR100779867B1 (en) 2007-11-27
KR20030009464A (en) 2003-01-29
EE200200599A (en) 2004-04-15
DE50105249D1 (en) 2005-03-10
WO2001083497A1 (en) 2001-11-08
EP1280812B1 (en) 2005-02-02
CA2407808C (en) 2013-06-25
CZ20023547A3 (en) 2003-02-12
DK1280812T3 (en) 2005-05-30
JP2003531914A (en) 2003-10-28
PL358328A1 (en) 2004-08-09
RU2266911C2 (en) 2005-12-27
IL152612A (en) 2009-11-18
HUP0300306A2 (en) 2003-06-28
EE05090B1 (en) 2008-10-15
HRP20020864A2 (en) 2004-12-31
BR0110459A (en) 2003-03-11
SK15602002A3 (en) 2003-04-01
NO20025209L (en) 2002-10-30
NO330438B1 (en) 2011-04-11
HK1055745A1 (en) 2004-01-21
IL152612A0 (en) 2003-06-24
AU2001262229B2 (en) 2007-01-25
CN1427845A (en) 2003-07-02
NZ522352A (en) 2004-06-25
ATE288442T1 (en) 2005-02-15
CA2407808A1 (en) 2002-10-30
JP5038572B2 (en) 2012-10-03
MXPA02010297A (en) 2003-04-25
AR028398A1 (en) 2003-05-07
HUP0300306A3 (en) 2004-10-28
CN1216890C (en) 2005-08-31
AU6222901A (en) 2001-11-12
YU81502A (en) 2006-05-25
ZA200208928B (en) 2003-10-07
DE10021731B4 (en) 2005-12-08
DE10021731A1 (en) 2001-11-15
PT1280812E (en) 2005-05-31

Similar Documents

Publication Publication Date Title
ATE316083T1 (en) ADAMANTANDE DERIVATIVES
SE0200920D0 (en) Novel compounds
SE0103836D0 (en) Novel compounds
BR0212871A (en) Microemulsion forming concentrate, microemulsion and methods of applying a herbicidal and a herbicidal composition and of preparing a microemulsion forming concentrate and a microemulsion
NO20024772D0 (en) Percyquinnin, process for its preparation and its use as a drug
NO20050134L (en) Diphenyllazidide ions substituted with acid groups, process for their preparation, drugs containing these compounds and their use
BR0316375A (en) Diazinopyrimidines
NO20024177L (en) Pharmaceutical preparations containing azetidine derivatives, the new azetidine derivatives and their preparation
SE0104251D0 (en) Novel compounds
SE0300480D0 (en) Novel compounds
IL168718A (en) Biguanide derivatives, compositions comprising the derivatives, process for preparing an antimicrobial compound and use of the derivatives in the preparation of medicaments
SE0302192D0 (en) Novel compounds
BRPI0413094A (en) quinoline derivatives and their use in therapy
CY1112960T1 (en) URINE PRODUCERS, METHODS FOR THEIR PREPARATION AND USE OF THESE
DE602004008959D1 (en) BENZOÄBÜÄ1,4ÜDIOXEPINDERIVATE
DK1517890T3 (en) Cationically substituted diphenyllazetidinones, processes for their preparation, drugs containing these compounds and their use
BR0213066A (en) Cyanoacetyl Compounds
ATE238981T1 (en) ANTITUMOR ACTIVES
UA93529C2 (en) Salts of 9-oxoacridine-10-acetic acid with 1-alkylamno-1-desoxy-polyols
NO20025209D0 (en) Cyclipostins, their preparation and use
MXPA04005484A (en) Method for preparing echinocandin derivatives.
MXPA04004621A (en) Nucleosides preparation thereof and use as inhibitors of rna viral polymerases.
MXPA04005809A (en) Protein kinase inhibitors.
SE0202693D0 (en) Compounds
SE0102057D0 (en) New Salts I

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees